Heart Bypass Drug May Need 'Difference-Finding' Trial, FDA Says - Internal Medicine News Digital Network PDF Print
Internal Medicine News Digital Network
The FDA's Cardiovascular and Renal Drugs Advisory Committee will likely deliberate on the required size of a clinical study for Portola Pharmaceuticals'

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.